Crohn’s disease: considerations for treatment choice during pregnancy

Экспериментальная и клиническая гастроэнтерология 2026 Open access

Read full text
Authors: A. A. Markova, Elena Igorevna Kashkina, Natalia M. Nikitina, I. V. Kozlova, Апаркина Алена Васильевна, D. A. Akhomgotova, A. A. Babakhanova, A. A. Astashkina
DOI: 10.31146/1682-8658-ecg-244-12-135-141
Cited by: 0
References: 11

Abstract

This article presents a clinical case of a pregnant patient with Crohn’s disease. When managing pregnant women with inflammatory bowel disease, the priority is maintaining disease remission using medications approved for use during pregnancy, including modern genetically engineered biological therapies, to preserve the health of both mother and fetus. In this case, the situation was complicated by a history of multiple surgeries and a functioning ileostomy. Collaborative care by a multidisciplinary team of specialists prevented complications and resulted in a successful pregnancy, delivery, and postpartum period.

Fields of Study & Subjects

Pregnancy and Medication Impact Inflammatory Bowel Disease Cardiovascular Issues in Pregnancy

Publication details

Journal / source
Экспериментальная и клиническая гастроэнтерология
Issue
12
Pages
135–141
Publication date
26 February 2026
Language
EN